Filing Details
- Accession Number:
- 0001639637-16-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-13 20:09:48
- Reporting Period:
- 2016-07-13
- Filing Date:
- 2016-07-13
- Accepted Time:
- 2016-07-13 20:09:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1639637 | L. Karen Smith | Connaught House, 1 Burlington Rd, Fl. 4 Dublin 4 L2 | Global Head Of R&D And Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2016-07-13 | 580 | $143.63 | 13,574 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects purchases of ordinary shares executed in multiple transactions at prices ranging from $143.19 to $143.96. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were made.
Billionaire Hedge Funds
